DnaJC7 in Amyotrophic Lateral Sclerosis.

Area of Science:

• Neuroscience
• Molecular Biology
• Genetics

Background:

• Protein misfolding underlies neurodegenerative diseases like amyotrophic lateral sclerosis (ALS).
• Misfolded proteins aggregate in neurons, forming inclusions characteristic of ALS.
• Cellular protein quality control, involving molecular chaperones, prevents and resolves protein misfolding.

Purpose of the Study:

• To review the expression, interaction, and function of the molecular chaperone DnaJC7.
• To explore the role of DnaJC7 in ALS pathogenesis.
• To propose a loss-of-function mechanism for DNAJC7 variants in ALS.

Main Methods:

• Review of existing literature on DnaJC7, protein quality control, and ALS.
• Analysis of genetic data linking DNAJC7 variants to familial and sporadic ALS.
• Integration of knowledge on chaperone interactions (Hsp70, Hsp90) and DnaJC7 structure.

Main Results:

• DnaJC7 is an evolutionarily conserved molecular chaperone linking Hsp70 and Hsp90 chaperone machineries.
• Pathogenic variants in the DNAJC7 gene are associated with familial and sporadic ALS.
• The precise molecular pathophysiology of DnaJC7 in ALS remains largely unexplored.

Conclusions:

• Pathogenic DNAJC7 variants likely cause ALS through a loss-of-function mechanism.
• Defects in DnaJC7-mediated chaperoning may contribute to neurodegeneration in ALS.
• Further research is needed to fully elucidate DnaJC7's function and its role in ALS.